Answers are grounded in this paper and cite their sources.
While immunotherapy seems to be a promising treatment with limited side effects in several other tumor entities, there is currently no data supporting tumor response in FLC.
No takes yet. Share an insight, caveat, or question.
Bauer et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: